Pharmalot By Ed Silverman FTC says pay-to-delay cases fell, prompting trade group to argue legislation isn’t needed
Pharmalot By Ed Silverman Pharmalittle: Colorado is first U.S. state to cap insulin prices; JP Morgan cuts ties with Purdue
Pharmalot By Ed Silverman In possible blueprint for other states, Ohio attorney general floats proposals to rein in PBMs
Pharmalot By Ed Silverman A growing number of states are eyeing laws to prohibit a controversial cost-sharing tool
Pharmalot By Ed Silverman Pharmalittle: Generic chief at Novartis unit leaves; how Ned Sharpless got to the top of the FDA
Pharmalot By Ed Silverman Pharmalittle: Lilly to sell version of insulin at half price; senators push drug price gouging bill
Pharmalot By Ed Silverman California reports show changes in drug spending as two companies sue over disclosure
First Opinion By Lello Tesema and Stephen Merjavy Deported veterans should not be denied the health care they’ve earned
Pharmalot By Ed Silverman Mr. Quixote goes to Washington? A bill would allow Medicare to negotiate drug prices
Pharmalot By Ed Silverman Congress isn’t acting to curb drug prices, so states are stepping up. Here’s how
Pharmalot By Ed Silverman Drug pricing battle moves to Ohio as dueling ads begin over a ballot measure
Pharmalot By Ed Silverman Q&A: Vermont legislator says drug pricing law is the start of a ‘long battle’
Pharmalot By Ed Silverman Long-awaited Senate report suggests ways to blunt impact of rising drug prices
Pharmalot By Ed Silverman 21st Century Cures bill would weaken requirements for disclosing industry ties